Revenue: The sum of all revenue fields included for a company's operating activities.
MEI Pharma, Inc. (MEIP) had Revenue of $65.30M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
|
Revenue |
$65.30M |
$17.78M |
|
-- |
|
$65.30M |
|
$50.76M |
|
$14.54M |
|
$3.24M |
|
$17.78M |
|
$17.78M |
|
$17.78M |
|
$17.78M |
|
$17.78M |
|
$17.78M |
|
$14.54M |
|
$25.82M |
|
6.66M |
|
6.66M |
|
$2.67 |
|
$2.67 |
|
| Balance Sheet Financials | |
$40.77M |
|
$0.39M |
|
$0.61M |
|
$41.38M |
|
$8.36M |
|
-- |
|
-- |
|
$8.36M |
|
$33.02M |
|
$33.02M |
|
$33.02M |
|
6.66M |
|
| Cash Flow Statement Financials | |
$-50.47M |
|
$49.14M |
|
$-11.87M |
|
$16.91M |
|
$3.71M |
|
$-13.20M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
22.27% |
|
22.27% |
|
39.55% |
|
27.23% |
|
27.23% |
|
$-50.48M |
|
-- |
|
-- |
|
-- |
|
1.58 |
|
-- |
|
-- |
|
-- |
|
53.84% |
|
53.84% |
|
42.97% |
|
53.84% |
|
$4.96 |
|
$-7.58 |
|
$-7.58 |
|